Ashraf Amanullah files SEC Form 4 disclosures for aTYR PHARMA INC. They have made 1 open-market trade across 1 company since 2016, most recently 2018-05-31.
CIK 0001670631
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $25K since 2016, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| LIFE | 26,264 | $984K |
Shares reported on the most recent Form 4, priced at the 2018-06-07 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.